Target intelligence / Profile preview

Intestinal movement

Molecular classification
G protein-coupled receptor, Ion channel, Interstitial cells of Cajal
01

Overview

"Intestinal movement" refers to the coordinated contraction and relaxation of smooth muscle in the gastrointestinal tract, enabling propulsion and mixing of luminal contents. This process, termed peristalsis, relies on the integration of electrical activity generated by interstitial cells of Cajal (the gut "pacemakers"), neurotransmitter release from enteric neurons (notably acetylcholine, serotonin, nitric oxide), and hormonal signals (such as motilin and secretin)[3][4][8]. There is no single molecular target for "intestinal movement"; rather, it is the result of interaction among various cellular and molecular systems that regulate muscle contraction and relaxation across different segments of the GI tract[1][6][7].

Other names
Gastrointestinal motilityPeristalsisIntestinal peristalsisGI motility
02

Mechanism of action

Stimulation or inhibition of neurotransmitter release (acetylcholine, serotonin, nitric oxide); Modulation of smooth muscle contractility (via calcium channel, G protein-coupled receptor signaling, kinase pathways); Agonism or antagonism of specific receptors (motilin receptor, serotonin 5-HT4 receptor, opioid receptors).

03

Biological functions

Movement/motility of intestinal contentsMixing of digestive contentsAbsorption facilitationPropulsion of waste
04

Disease associations

Gastrointestinal motility disorders (e.g., gastroparesis, diarrhea, constipation)Inflammatory bowel disease (as abnormal motility plays a role)Irritable bowel syndrome
05

Safety considerations

Therapeutic modulation can cause diarrhea, constipation, abdominal cramping, or more severe consequences like obstruction or perforation if improperly managed
06

Interacting drugs

Prokinetics (e.g., metoclopramide: dopamine D2 antagonist, erythromycin: motilin receptor agonist)

3 more in the full profile.

07

Biomarkers

None specific for "intestinal movement" as a target; indirect markers may include bowel transit time or motility testing, but no molecular biomarker exists for the process as a whole.

Beyond the preview

Go deeper on Intestinal movement.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Intestinal movement.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call